Mirtazapine is a tetracyclic piperazino-azepine antidepressant agent that was initially approved for the treatment of major depressive disorder (MDD) in the Netherlands in 1994. This drug was first manufactured by Organon Inc., and received FDA approval in 1997 for the treatment of major depressive disorder. The effects of this drug may be observed as early ...
This drug is indicated for the treatment of major depressive disorder and its associated symptoms.
...
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.